Ittai Harel

Mr. Harel, General Partner at Pitango Venture Capital is a veteran of the life sciences industry. He has fifteen years of experience, covering a wide range of activities, from basic business and technology development to corporate executive management, in areas such as pharmaceutical development, drug delivery, medical devices and diagnostics.

Before joining Pitango, Mr. Harel was Director of Corporate Development at Nektar Therapeutics (NASDAQ: NKTR) where he was responsible for strategic planning, in-licensing and M&A activities. Prior to his role at Nektar, he held various management positions at leading companies both in Israel and in the U.S. including IDEXX Laboratories (NASDAQ: IDXX) and IDGene Pharmaceuticals.